FdaApplication

ANDA 203503

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLENMARK PHARMACEUTICALS LTD
application_typeANDA
approval_date2015-09-02

Products (2)

ProductActive ingredientStrengthDosage form
VORICONAZOLEVORICONAZOLE50MGTABLET;ORAL
VORICONAZOLEVORICONAZOLE200MGTABLET;ORAL

2 products